Solid tumors, including breast cancer, exhibit an elevated expression of SR-B1, an HDL receptor responsible for selectively removing esterified cholesterol and miRs, and is associated with the poor prognosis of breast cancer [20,28]. Here, SCARB1 is linked to breast cancer.